Beta
178414

Spexin and Metformin Comparative Ameliorated Ovarian and Liver Function Changes in Letrozole-Induced Polycystic Ovary Syndrome in Rats (Histological, Biochemical, Immunohistochemical and Morphometric Study)

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is characterized by polycystic ovarian follicle morphology, ovulatory dysfunction, hyperandrogenism and insulin resistance. Spexin has a role in satiety control, lipid and glucose metabolism. Metformin is an insulin sensitizing agent that has some hepato-protective functions.
Aim: This study aimed to declare and compare the effect of spexin and metformin treatment on ovarian and liver function changes in letrozole-induced PCOS in rats and the possible mechanisms involved.
Materials and Methods: Thirty-two adult female Wistar albino rats divided into control, polycystic ovary syndrome (PCOS), PCOS metformin-treated, and PCOS spexin-treated groups. In PCOS groups, rats were given oral letrozole 0.5 mg/kg dissolved in 0.9% NaCl once daily along the study. In PCOS metformin-treated group, rats were treated with metformin hydrochloride orally (300 mg/kg/day) for the last 4 weeks. In PCOS spexin-treated group, rats were treated with spexin i.p. 35 μg/kg/day, dissolved in normal saline for the last 4 weeks.
Results: In PCOS group, there was a significant increase in; BMI, relative ovarian weight, HOMA-IR, serum (LH, FSH, testosterone, insulin, glucose, TC, TG, LDL, ALT, AST, alkaline phosphatase, total & direct bilirubin) and hepatic (MDA, NO & TNF-α), with a significant decrease in; serum [estradiol, progesterone, HDL, albumin and spexin] and hepatic GPX, when compared with the control group. Histopathological results showed ovaries of PCOS marked expression of caspase-3 and P53 and decreased KI67 expression of granulosa and theca cells. Vacuolated hepatocytes, dilated and congested portal vein and positive reaction of immunostaining with αSMA, caspase and TNFα. Treatment of PCOS rats with either metformin or spexin reversed these changes significantly.
Conclusion: Spexin serum level could be used as a metabolic biomarker for polycystic ovary syndrome. Also, treatment with either metformin or spexin ameliorated ovarian and hepatic dysfunctions in rat model of PCOS through their insulin sensitizing, anti-oxidant and anti-inflammatory effects.

DOI

10.21608/ejh.2021.76972.1486

Keywords

liver function, Metformin, polycystic ovary syndrome, Spexin

Authors

First Name

Khaled

Last Name

Abulfadle

MiddleName

Abdelfattah

Affiliation

Physiology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Email

khafadle@gmail.com

City

-

Orcid

0000-0001-8679-3571

First Name

Husam

Last Name

Edrees

MiddleName

-

Affiliation

Physiology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Email

hmasmaaiel@qu.edu.sa

City

-

Orcid

0000-0003-4618-9083

First Name

Nancy

Last Name

Hassan

MiddleName

Husseiny

Affiliation

Human Anatomy and Embryology department, Faculty of Medicine, Zagazig University, Egypt

Email

nancyhusseiny@gmail.com

City

-

Orcid

0000-0002-8497-0412

First Name

Heba

Last Name

Mohammed

MiddleName

Osama

Affiliation

human anatomy and embryology,faculty of medicine,Zagazig University

Email

yassin_mekkawy@yahoo.com

City

zagazig

Orcid

0000-0002-0944-6186

Volume

45

Article Issue

3

Related Issue

37238

Issue Date

2022-09-01

Receive Date

2021-05-21

Publish Date

2022-09-01

Page Start

774

Page End

790

Print ISSN

1110-0559

Online ISSN

2090-2417

Link

https://ejh.journals.ekb.eg/article_178414.html

Detail API

https://ejh.journals.ekb.eg/service?article_code=178414

Order

8

Type

Original Article

Type Code

119

Publication Type

Journal

Publication Title

Egyptian Journal of Histology

Publication Link

https://ejh.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023